Novo Nordisk A/s Earnings

Novo Nordisk A/s’s revenue jumped 19.49% since last year same period to $78087Mn in the Q1 2025. On a quarterly growth basis, Novo Nordisk A/s has generated -8.87% fall in its revenue since last 3-months.

Novo Nordisk A/s’s net profit jumped 14.28% since last year same period to $29034Mn in the Q1 2025. On a quarterly growth basis, Novo Nordisk A/s has generated 2.85% jump in its net profits since last 3-months.

Novo Nordisk A/s’s net profit margin fell -4.37% since last year same period to 37.18% in the Q1 2025. On a quarterly growth basis, Novo Nordisk A/s has generated 12.85% jump in its net profit margins since last 3-months.

Novo Nordisk A/s’s price-to-earnings ratio after this Q1 2025 earnings stands at 19.24.

Novo Nordisk A/s’s earning per share (EPS) estimates for the current quarter stand at 1.01 - a -83.11% fall from last quarter’s estimates.

Novo Nordisk A/s’s earning per share (EPS) estimates for the current year stand at 1.01.

Novo Nordisk A/s’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Novo Nordisk A/s has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.